Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 80,000 shares at $58.22 ($4.7M) on 2021-01-27, disclosed to the SEC on 2021-01-29.
Open-market sale of $4.7M ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.22 | 17,499 | $1.0M | 21.6% |
| 2 | $58.22 | 17,499 | $1.0M | 21.6% |
| 3 | $59.24 | 14,233 | $843K | 17.9% |
| 4 | $59.24 | 14,233 | $843K | 17.9% |
| 5 | $60.01 | 8,268 | $496K | 10.5% |
| 6 | $60.01 | 8,268 |
| $496K |
| 10.5% |
| Total | $58.95 avg | 80,000 | $4.7M | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |
| ADPT | SELL | 2020-11-10 | $592K | — | Filing → |